DALLAS, May 18, 2017 /PRNewswire/ --
Puration, Inc. (USOTC: PURA) has published an online on demand earnings presentationreviewing the Company's first quarter 2017 financial report. In addition to a review of the most recent financial results, which highlights the Company's first reported revenue from its patented cannabis extraction business, the report also includes
REVIEW THE ENTIRE PURA EARNINGS REPORT
To learn more about Puration: purationinc.com
To learn more about NCM Biotech: ncmbiotech.com
Disclaimer/Safe Harbor: This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies' contracts, the companies' liquidity position, the companies' ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.
Puration Contact: Brian Shibley, CEO email@example.com +1-214-937-9097
SOURCE Puration, Inc.
Subscribe to our Free Newsletters!
Cachexia refers to severe muscle and fat loss, anorexia and marked weight loss due to an underlying ...
Exotropia or outward eye deviation is a form of squint. Proper evaluation and timely intervention ...
Glaucoma is a group of disorders involving the optic nerve, often associated with a rise in ...View All